3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
11
Terminated
3
Active not recruiting
3
Unknown
1
Recruiting
1
Not yet recruiting
1
Approved for marketing
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
15
Endocrine
15
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Conditions
Colorectal Neoplasms
296
Carcinoma, Hepatocellular
212
Stomach Neoplasms
155
Pancreatic Neoplasms
155
Rectal Neoplasms
114
Esophageal Neoplasms
84
Colonic Neoplasms
78
Esophageal Squamous Cell Carcinoma
51
Cholangiocarcinoma
48
Liver Neoplasms
46
Biliary Tract Neoplasms
36
Neoplasms
31
Breast Neoplasms
31
Neoplasm Metastasis
28
Gastrointestinal Neoplasms
26
Carcinoma, Non-Small-Cell Lung
26
Lung Neoplasms
20
Disease
18
Prostatic Neoplasms
17
Uterine Cervical Neoplasms
16
Recurrence
16
Ovarian Neoplasms
14
Colorectal Neoplasms, Hereditary Nonpolyposis
13
Endometrial Neoplasms
12
Head and Neck Neoplasms
11
Adenocarcinoma Of Esophagus
11
Gallbladder Neoplasms
10
Colonic Polyps
10
Anus Neoplasms
10
Melanoma
9
Interventions
trametinib
1
dabrafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Thyroid Cancer, Papillary
×
Gastrointestinal
×
Clear all
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled